Strategies for the application of biomar
✍
Kapil Dhingra; Victor Vogel; Nour Sneige; Aysegul Sahin; Marcelo Aldaz; Gabriel
📂
Article
📅
1993
🏛
John Wiley and Sons
🌐
English
⚖ 648 KB
Current chemoprevention trial designs based on epidemiological risk assessment and occurrence of cancer as an endpoint are inefficient and expensive. Novel biomarkers are needed to facilitate the development of chemopreventive interventions. The following four categories of biomarkers may be useful